Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm.
Saved in:
| Title: | Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. |
|---|---|
| Authors: | Bataller A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Gener-Ricos G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Almanza-Huante E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Urrutia S; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Rodriguez-Sevilla JJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. |
| Source: | Blood advances [Blood Adv] 2024 Jun 11; Vol. 8 (11), pp. 2695-2706. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38513082 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bataller+A%22">Bataller A</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Gener-Ricos+G%22">Gener-Ricos G</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Almanza-Huante+E%22">Almanza-Huante E</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Chien+KS%22">Chien KS</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Urrutia+S%22">Urrutia S</searchLink>; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Bazinet+A%22">Bazinet A</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Sevilla+JJ%22">Rodriguez-Sevilla JJ</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Hammond+D%22">Hammond D</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Sasaki+K%22">Sasaki K</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Takahashi+K%22">Takahashi K</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22DiNardo+CD%22">DiNardo CD</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Ravandi+F%22">Ravandi F</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Borthakur+G%22">Borthakur G</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Kadia+TM%22">Kadia TM</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Kanagal-Shamanna+R%22">Kanagal-Shamanna R</searchLink>; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Kantarjian+HM%22">Kantarjian HM</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Garcia-Manero+G%22">Garcia-Manero G</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Montalban-Bravo+G%22">Montalban-Bravo G</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2024 Jun 11; Vol. 8 (11), pp. 2695-2706. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38513082 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2024012565 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2695 Titles: – TitleFull: Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bataller A – PersonEntity: Name: NameFull: Gener-Ricos G – PersonEntity: Name: NameFull: Almanza-Huante E – PersonEntity: Name: NameFull: Chien KS – PersonEntity: Name: NameFull: Urrutia S – PersonEntity: Name: NameFull: Bazinet A – PersonEntity: Name: NameFull: Rodriguez-Sevilla JJ – PersonEntity: Name: NameFull: Hammond D – PersonEntity: Name: NameFull: Sasaki K – PersonEntity: Name: NameFull: Takahashi K – PersonEntity: Name: NameFull: DiNardo CD – PersonEntity: Name: NameFull: Ravandi F – PersonEntity: Name: NameFull: Borthakur G – PersonEntity: Name: NameFull: Kadia TM – PersonEntity: Name: NameFull: Kanagal-Shamanna R – PersonEntity: Name: NameFull: Kantarjian HM – PersonEntity: Name: NameFull: Garcia-Manero G – PersonEntity: Name: NameFull: Montalban-Bravo G IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 06 Text: 2024 Jun 11 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 8 – Type: issue Value: 11 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |